NCT03535779View on ClinicalTrials.gov

Characterisation of Human B Cell Maturation in Response to Vaccination

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

March 6, 2017

Primary Completion Date

June 15, 2017

Study Completion Date

March 13, 2018

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Hepatitis B

The Hepatitis B virus, is a double stranded DNA virus that prevents Hepatitis B in the population

BIOLOGICAL

Tetanus Toxoid

The Tetanus vaccine, also known as tetanus toxoid (Td/IVP), is an inactive vaccine used to prevent tetanus in the population

Trial Locations (1)

Unknown

Dr Lucy Garvey, Paddington

All Listed Sponsors
lead

Imperial College London

OTHER

NCT03535779 - Characterisation of Human B Cell Maturation in Response to Vaccination | Biotech Hunter | Biotech Hunter